Vapotherm, Inc. Announces CE Mark Approval for Flowrest® Homecare Device

January 6, 2011

STEVENSVILLE, Md., Jan. 6, 2011 /PRNewswire-USNewswire/ — Vapotherm, the global leader in High Flow Therapy products, announced receiving CE marking for Flowrest®, a device designed for homecare and other low acuity environments.

The Flowrest® device delivers warmed humidified high-flow breathing gases for treating spontaneously breathing patients via nasal cannula. Flowrest® is designed for ease of use in the home and includes an integrated blower and patent-pending humidification and breathing circuit technology.

“We are excited to expand our product portfolio and greet the pent-up demand for a high flow therapy device that is comfortable, cost-effective and easy to use specifically for patients in the home and other low acuity environments,” said Nick Macmillan, Home Care Segment Manager.

Vapotherm, Inc. is a privately held manufacturer of respiratory care devices for hospitals and home care use based in Stevensville, Maryland. The Company is dedicated to the development of innovative, noninvasive technologies for respiratory therapy, especially for the treatment of chronic lung and acute breathing disorders. For more information, visit www.vtherm.com.

    Contact:  Kevin Thibodeau, EVP
     Sales and Marketing
    Vapotherm, Inc.
    198 Log Canoe Circle
    Stevensville, MD 21666
    Phone (410) 604-3977
    Fax (410) 604-0707

SOURCE Vapotherm, Inc.

Source: newswire

comments powered by Disqus